Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
Hello, and welcome, everyone, to the Cencora Q1 fiscal year 2025 earnings call. My name is Becky, and I'll be your operator today. (Operator Instructions) I will now hand over to your host, Head of ...
Cencora assumes no obligation to update any ... Another example is our enterprise leadership team just returned from the United Kingdom, visiting elements of our international operations, spending ...
AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...
Revvity announced an expansion of its work with Genomics England that leverages both organizations' expertise and resources to advance critical genomic initiatives across the United Kingdom.
Hosted on MSN20d
Revvity Gears Up for Q4 Earnings: What's in the Offing?Revvity, Inc. RVTY is slated to report fourth-quarter 2024 results on Jan. 31, before market open. In the last reported quarter, the company delivered an earnings surprise of 13.27%. RVTY’s earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback